H
Health Catalyst, Inc. (HCAT)
NMS – Real Time Price. Currency in USD
1.48
+0.10 (7.25%)
At close: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
1.48
+0.10 (7.25%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.87 | 2.19 | 9.0 | |
| Quick ratio | 1.87 | 1.96 | 9.0 | |
| Debt to Equity | 0.70 | 1.16 | 7.0 | |
| Debt to Assets | 0.34 | 2.94 | 6.0 | |
| Interest coverage | -1.41 | -28.30 | 1.0 | |
| Weighted average score | 6.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 276M | 296M | 307M | 311M | 311M |
| Gross Profit | 87M | 93M | 100M | 104M | 104M |
| Operating Income | -123M | -86M | -55M | -41M | -48M |
| Net Income | -137M | -118M | -70M | -178M | -178M |
| EBITDA | -71M | -41M | -13M | 10M | 3M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -12.84 | 59.99 | 5.5 |
| Next quarter | -12.35 | -26.26 | 1.0 |
| Current year | -9.94 | -37.54 | 1.0 |
| Next year | -0.14 | 23.36 | 5.5 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -2.14 | -309.48 | 33.33 | 185.32 | 5.5 |
| Y/Y | -6.18 | -340.3 | 100 | 153.82 | 5.5 |
| 3y average | 4.07 | -33.62 | 69.55 | -432.84 | 4.0 |
| 5y average | 10.9 | -24.74 | 56.94 | -267.52 | 4.8 |
| Weighted average score | 5.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $171.2M significantly exceeds cash reserves ($50.8M), raising financial stability concerns
Total current assets $167.5M exceed Total current liabilities $89.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.7) is well below the industry average (1.2), showcasing prudent financial management
Interest coverage ratio (-1.4x) is dangerously low, suggesting debt repayment risks
The company generates positive free cash flow $4.5M, supporting its financial health